TrialThe British journal of dermatology2020

Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study.

R Dummer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.